tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 1144 are a BUY (92.86%), 84 are a HOLD (6.82%), 4 are a SELL (0.32%).
Analyst Raghuram Selvaraju, carries an average stock price target met ratio of 34.71% that have a potential upside of 54.52% achieved within 193 days. Previously, Raghuram Selvaraju worked at HC WAINWRIGHT.
Raghuram Selvaraju’s has documented 2,227 price targets and ratings displayed on 129 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on OVID, Ovid Therapeutics at 22-Dec-2025.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for EVOK (EVOKE PHARMA) at 7/18/2016. The price target of $288 was fulfilled within 3 days with a profit of $128.16 (30.8%) receiving and performance score of 102.65.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
Since 12-May-2021
$12
$-1.72 (-12.54%)
$7
6 months 14 days ago
(25-Jun-2025)
8/13 (61.54%)
$-4.19 (-25.88%)
55
Buy
Since 16-Apr-2021
1 years 6 months 21 days ago
(18-Jun-2024)
10/37 (27.03%)
$101 (102.02%)
298
Sell
Since 06-May-2022
2 years 1 months 19 days ago
(20-Nov-2023)
1/3 (33.33%)
$-0.8 (-0.99%)
300
Hold
Since 25-Oct-2023
$20
$6.28 (45.77%)
$60
2 years 2 months 14 days ago
(25-Oct-2023)
3/22 (13.64%)
$5.8 (40.85%)
40
Hold
Since 04-May-2022
$25
$11.28 (82.22%)
$40
2 years 5 months 20 days ago
(19-Jul-2023)
2/5 (40%)
$3.4 (15.74%)
215
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
